These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Combination of phosphodiesterase-5 inhibitors and alpha-blockers in patients with benign prostatic hyperplasia: treatments of lower urinary tract symptoms, erectile dysfunction, or both? Carson CC BJU Int; 2006 Apr; 97 Suppl 2():39-43; discussion 44-5. PubMed ID: 16507053 [TBL] [Abstract][Full Text] [Related]
13. [Intraurethrally applicated alprostadil for the treatment of organic erectile dysfunction in practice: a multicenter clinical monitoring study (noninterventional investigation)]. Potempal AJ; Potempa DM; Görlich HD; Stolpmann RM Arzneimittelforschung; 2007; 57(6):299-308. PubMed ID: 17688074 [TBL] [Abstract][Full Text] [Related]
14. [New treatment options for erectile dysfunction. Pharmacologic and nonpharmacologic options]. Sperling H; Lümmen G; Schneider T; Rübben H Herz; 2003 Jun; 28(4):314-24. PubMed ID: 12825147 [TBL] [Abstract][Full Text] [Related]
15. Design and evaluation of nitrosylated alpha-adrenergic receptor antagonists as potential agents for the treatment of impotence. de Tejada IS; Garvey DS; Schroeder JD; Shelekhin T; Letts LG; Fernández A; Cuevas B; Gabancho S; Martínez V; Angulo J; Trocha M; Marek P; Cuevas P; Tam SW J Pharmacol Exp Ther; 1999 Jul; 290(1):121-8. PubMed ID: 10381767 [TBL] [Abstract][Full Text] [Related]
16. Erectile dysfunction: the Viagra revolution. Harv Mens Health Watch; 2005 Apr; 9(9):1-6. PubMed ID: 18217258 [No Abstract] [Full Text] [Related]
17. Phosphodiesterase 5 inhibitors in the management of benign prostatic hyperplasia and erectile dysfunction: the best of both worlds. Wong P; Lawrentschuk N; Bolton DM Curr Opin Urol; 2009 Jan; 19(1):7-12. PubMed ID: 19057210 [TBL] [Abstract][Full Text] [Related]